Technology Overview Researchers at Oregon Health & Science University have developed the first and only cell based PKAN model whereby human fibroblasts with respiratory dysfunction are maintained and utilized to screen compounds for biological activity against PKAN cellular phenotypes associated with PANK2 gene mutations.
Licensing Opportunity
This technology is available for licensing.